Funded Local Who is raising money in your own backyard?

Vancouver- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has entered into an agreement with CR Intrinsic Investments, LLC, an investment fund managed by CR Intrinsic Investors, LLC, an affiliate of S.A.C. Capital Advisors, LLC to purchase Series A convertible preferred shares for gross proceeds of US$25 million. Proceeds of the financing will be used for general corporate purposes, costs associated with the ongoing strategic process and continued development of Cardiome’s clinical programs.

Vancouver, B.C. – July 21, 2008 – Lignol Energy Corporation (TSX-V: LEC) (“Lignol” or “the Company”), a leading technology company in the cellulosic ethanol and biorefining sector, today announced that its wholly-owned subsidiary, Lignol Innovations Ltd. has been awarded $1.96 million in funding from the Government of British Columbia’s $25 million Innovative Clean Energy (“ICE”) Fund.

See NeoVasc Company listing for more details.

Financing to Advance Commercialization of Expanded Portfolio of Vascular Products

Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Brossard, QC, June 27, 2008– Railpower Technologies Corp. (TSX: P) (the “Corporation”) is pleased to announce that it has closed its previously announced $20 Million private placement with Teachers. The proceeds will be used to finance, among other things, construction of a manufacturing facility in Saint- Jean-sur-Richelieu.

Victoria, B.C., June 26, 2008 – CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it will issue 3,500,000 units at a price of $0.10 per unit for gross proceeds of $350,000. The proceeds are intended to replace the funds that were expected to be received by the Company under the fourth and final tranche of the Company’s previously announced convertible note financing, which fourth tranche will not be completed.

VANCOUVER, June 26 - OneMove Technologies Inc. ("OneMove" or the "Company") (TSX-V: OM), a provider of a leading web-based real estate transaction platform, today announces plans to conduct a non-brokered private placement for total proceeds of up to $400,000.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, BC – June 20, 2008 – IP Applications Corp. (the “Company”) (IPX: TSX-V) today announces that it intends, subject to receipt of all necessary regulatory approvals, to complete a non-brokered private placement to raise between $750,000 and $1,500,000 through the issuance of up to 7,500,00 units at a price of $0.20 per unit (the “Offering”).